US Patent Number
Compounds for treating abuse of nicotinic receptor agonists, addiction to psychostimulant drugs, addiction to opiates, addiction to alcohol, addiction to tobacco products, addiction to nicotine, schizophrenia and related diseases, depression and related conditions, Alzheimer's disease, Parkinson's disease, irritable bowel syndrome, and colitis. The compounds competitively inhibit central nervous system acting nicotinic receptor agonists and act at the putative α3β2* and α4β2 neuronal nicotinic receptors in the central nervous system.
University of Kentucky Research Foundation, Lexington, KY (US)
Crooks, Peter A.; Dwoshin, Linda; Xu, Rui; and Ayers, Joshua T., "Chain-Modified Pyridino-N Substituted Nicotine Compounds for Use in the Treatment of CNS Pathologies" (2006). Pharmaceutical Sciences Faculty Patents. 45.